Related Experiment Video
Updated: May 27, 2025
08:02
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.5K
Exosomes: a double-edged sword in cancer immunotherapy
Jiayi Chen1, Siyuan Hu1, Jiayi Liu1
1School of Life Sciences Jilin University Changchun China.
Medcomm
|February 19, 2025
Summary
Extracellular vesicles called exosomes show promise for cancer immunotherapy by modulating immune responses. Understanding their complex immune-activating or -suppressing roles is key to developing effective exosome-based cancer treatments.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Immunotherapy is a key cancer treatment strategy, offering advantages over conventional methods.
- Extracellular vesicles, specifically exosomes, are investigated for their potential in cancer immunotherapy due to their cargo-carrying capabilities.
- Exosomes can influence target cell phenotype and immunomodulatory functions, impacting the tumor microenvironment.
Purpose of the Study:
- To review the molecular mechanisms of exosome function in cancer.
- To analyze the impact of exosomes on the tumor microenvironment (TME).
- To highlight the balance between immune suppression and activation in exosome-based therapies.
Main Methods:
- Literature review focusing on molecular mechanisms of exosome function.
- Analysis of exosome cargo and its effect on immune cells.
- Examination of exosome impact on the tumor microenvironment.
Main Results:
- Exosomes possess dual roles, exhibiting either immunosuppressive or immune-activating properties based on their contents.
- The diverse origins and contents of exosomes create a complex interplay of immune modulation.
- Exosomes significantly impact the tumor microenvironment, influencing cancer progression.
Conclusions:
- A deep understanding of exosome molecular mechanisms is crucial for advancing cancer immunotherapy.
- Optimizing exosome-based therapies requires navigating the balance between immune suppression and activation.
- Further research is needed to overcome challenges and enhance exosome-based immunotherapies for cancer treatment.
Related Concept Videos
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
01:19Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
01:30Cancer Vaccines
327
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
327
02:40Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K